Guyasuta Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Guyasuta Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Buy	46,071 +5	+0%	+$287	0.14%	84
2026 Q1	$2.79M	Buy	46,066 +4	+0%	+$233	0.16%	79
2025 Q4	$2.48M	Sell	46,062 -195	-0.4%	-$9.38K	0.14%	76
2025 Q3	$2.09M	Sell	46,257 -1,795	-4%	-$83.8K	0.12%	86
2025 Q2	$2.22M	Buy	48,052 +409	+0.9%	+$20.1K	0.14%	80
2025 Q1	$2.91M	Sell	47,643 -1,049	-2%	-$61.1K	0.19%	68
2024 Q4	$2.75M	Sell	48,692 -759	-2%	-$42.4K	0.17%	68
2024 Q3	$2.56M	Buy	49,451 +1	+0%	+$47	0.16%	72
2024 Q2	$2.54M	Hold	49,450	–	–	0.19%	61
2024 Q1	$2.54M	Hold	49,450	–	–	0.18%	61
2023 Q4	$2.54M	Sell	49,450 -82	-0.2%	-$4.3K	0.18%	61
2023 Q3	$2.87M	Hold	49,532	–	–	0.22%	55
2023 Q2	$3.17M	Buy	49,532 +127	+0.3%	+$8.52K	0.23%	56
2023 Q1	$3.42M	Sell	49,405 -1,254	-2%	-$88.4K	0.26%	52
2022 Q4	$3.64M	Buy	50,659 +24,372	+93%	+$1.84M	0.29%	51
2022 Q3	$1.87M	Buy	26,287 +1,469	+6%	+$107K	0.16%	73
2022 Q2	$1.91M	Buy	24,818 +2	+0%	+$152	0.15%	78
2022 Q1	$1.81M	Buy	24,816 +960	+4%	+$64.5K	0.12%	89
2021 Q4	$1.49M	Sell	23,856 -13,585	-36%	-$797K	0.1%	107
2021 Q3	$2.21M	Buy	37,441 +14,612	+64%	+$962K	0.16%	76
2021 Q2	$1.52M	Buy	22,829 +1,208	+6%	+$78.8K	0.11%	103
2021 Q1	$1.36M	Buy	21,621 +258	+1%	+$16.1K	0.11%	108
2020 Q4	$1.32M	Hold	21,363	–	–	0.11%	98
2020 Q3	$1.29M	Hold	21,363	–	–	0.12%	87
2020 Q2	$1.26M	Buy	21,363 +397	+2%	+$23.7K	0.13%	81
2020 Q1	$1.17M	Buy	20,966 +470	+2%	+$28.7K	0.14%	79
2019 Q4	$1.31M	Buy	20,496 +3,199	+18%	+$183K	0.13%	86
2019 Q3	$877K	Sell	17,297 -500	-3%	-$23.5K	0.09%	110
2019 Q2	$807K	Sell	17,797 -1,548	-8%	-$72.1K	0.08%	118
2019 Q1	$923K	Sell	19,345 -2,265	-10%	-$113K	0.1%	109
2018 Q4	$1.12M	Sell	21,610 -8,500	-28%	-$457K	0.14%	88
2018 Q3	$1.87M	Sell	30,110 -4,020	-12%	-$239K	0.2%	66
2018 Q2	$1.89M	Buy	34,130 +1,496	+5%	+$80.8K	0.22%	61
2018 Q1	$2.06M	Sell	32,634 -3,615	-10%	-$233K	0.24%	57
2017 Q4	$2.22M	Buy	36,249 +140	+0.4%	+$8.76K	0.25%	54
2017 Q3	$2.3M	Hold	36,109	–	–	0.28%	49
2017 Q2	$2.01M	Buy	36,109 +9,265	+35%	+$504K	0.24%	55
2017 Q1	$1.46M	Buy	26,844 +3,059	+13%	+$168K	0.18%	67
2016 Q4	$1.39M	Sell	23,785 -650	-3%	-$35.5K	0.18%	69
2016 Q3	$1.32M	Hold	24,435	–	–	0.17%	74
2016 Q2	$1.8M	Hold	24,435	–	–	0.24%	55
2016 Q1	$1.56M	Hold	24,435	–	–	0.22%	58
2015 Q4	$1.68M	Hold	24,435	–	–	0.24%	56
2015 Q3	$1.45M	Buy	24,435 +252	+1%	+$16K	0.21%	58
2015 Q2	$1.61M	Hold	24,183	–	–	0.21%	58
2015 Q1	$1.56M	Buy	24,183 +2,401	+11%	+$150K	0.21%	61
2014 Q4	$1.28M	Buy	21,782 +850	+4%	+$47.9K	0.17%	71
2014 Q3	$1.07M	Buy	20,932 +350	+2%	+$17.5K	0.15%	82
2014 Q2	$998K	Hold	20,582	–	–	0.13%	92
2014 Q1	$1.07M	Sell	20,582 -1,778	-8%	-$94.6K	0.15%	82
2013 Q4	$1.19M	Sell	22,360 -1,000	-4%	-$50.9K	0.17%	72
2013 Q3	$1.08M	Buy	23,360 +200	+0.9%	+$8.78K	0.17%	73
2013 Q2	$1.03M	Buy	+23,160	New	+$1.01M	0.17%	76

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Guyasuta Investment Advisors's BMY Position: Q2 2026 in Review

Guyasuta Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.01% in Q2 2026, buying an estimated $287 and bringing the position to 46,071 shares worth $2.65M. The position accounts for 0.14% of the portfolio, ranked #84.

Guyasuta Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.64M in Q4 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Guyasuta Investment Advisors held 46,071 shares of Bristol-Myers Squibb worth $2.65M as of Q2 2026.
Guyasuta Investment Advisors bought 5 Bristol-Myers Squibb shares in Q2 2026, an estimated $287.
Bristol-Myers Squibb made up 0.14% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #84 holding.
Guyasuta Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Guyasuta Investment Advisors's Bristol-Myers Squibb position peaked at $3.64M in Q4 2022.
878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.